Signal #151215 · SEC 8-K

$COGT SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $COGT filing catalyst

Why did $COGT trigger an AI stock catalyst alert?

$COGT triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.0/10). Headline: Cogent Biosciences Reports Q3 Net Loss of $111.4M, Confirms Late 2026 PDUFA Targets. Key points: - Q3 net loss expanded to $111.4M versus $80.9M in the prior-year period. - R&D expenses increased to $75.1M driven by ongoing clinical trials. - Cash position of $791.1M funds operations into late 2028 ahead of late 2026 PDUFA dates.

How did $COGT stock react after the SEC filing?

After the SEC 8-K for $COGT, observed market reaction: T0 price $29.58. Past moves do not guarantee future results.

Where can I get real-time $COGT SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $COGT via Telegram and the VIP Web Terminal from €10/month.

$COGT

$COGT – Cogent Biosciences Reports Q3 Net Loss of $111.4M, Confirms Late 2026 PDUFA Targets

Cogent Biosciences, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $COGT

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (-1.0 / 10)

Q3 net loss expanded to $111.4M versus $80.9M in the prior-year period.
R&D expenses increased to $75.1M driven by ongoing clinical trials.
Cash position of $791.1M funds operations into late 2028 ahead of late 2026 PDUFA dates.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →